Logo image of VERO

VENUS CONCEPT INC (VERO) Stock Overview

USA - NASDAQ:VERO - US92332W3034 - Common Stock

2.22 USD
+0.08 (+3.74%)
Last: 10/29/2025, 11:59:12 AM

VERO Key Statistics, Chart & Performance

Key Statistics
Market Cap4.13M
Revenue(TTM)60.11M
Net Income(TTM)-41335000
Shares1.86M
Float1.83M
52 Week High14.5
52 Week Low2.06
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-50.78
PEN/A
Fwd PEN/A
Earnings (Next)11-13 2025-11-13/bmo
IPO2017-10-12
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


VERO short term performance overview.The bars show the price performance of VERO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15

VERO long term performance overview.The bars show the price performance of VERO in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of VERO is 2.22 USD. In the past month the price decreased by -6.96%. In the past year, price decreased by -54.76%.

VENUS CONCEPT INC / VERO Daily stock chart

VERO Latest News, Press Relases and Analysis

VERO Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.07 217.73B
ISRG INTUITIVE SURGICAL INC 62.65 193.37B
BSX BOSTON SCIENTIFIC CORP 33.99 148.58B
SYK STRYKER CORP 28.91 142.00B
MDT MEDTRONIC PLC 16.67 118.23B
BDX BECTON DICKINSON AND CO 12.78 52.27B
IDXX IDEXX LABORATORIES INC 52.44 50.38B
EW EDWARDS LIFESCIENCES CORP 32.13 48.48B
RMD RESMED INC 26.8 37.35B
GEHC GE HEALTHCARE TECHNOLOGY 16.55 35.22B
DXCM DEXCOM INC 40.51 27.01B
PHG KONINKLIJKE PHILIPS NVR- NY 16.65 26.77B

About VERO

Company Profile

VERO logo image Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. The company is headquartered in Toronto, Ontario and currently employs 292 full-time employees. The company went IPO on 2017-10-12. The firm develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.

Company Info

VENUS CONCEPT INC

235 Yorkland Blvd Suite 900

TORONTO ONTARIO M2J 4Y8 CA

CEO: Domenic Serafino

Employees: 292

VERO Company Website

VERO Investor Relations

Phone: 18778488430

VENUS CONCEPT INC / VERO FAQ

What does VENUS CONCEPT INC do?

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. The company is headquartered in Toronto, Ontario and currently employs 292 full-time employees. The company went IPO on 2017-10-12. The firm develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.


What is the current price of VERO stock?

The current stock price of VERO is 2.22 USD. The price increased by 3.74% in the last trading session.


What is the dividend status of VENUS CONCEPT INC?

VERO does not pay a dividend.


What is the ChartMill technical and fundamental rating of VERO stock?

VERO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


On which exchange is VERO stock listed?

VERO stock is listed on the Nasdaq exchange.


Can you provide the sector and industry classification for VENUS CONCEPT INC?

VENUS CONCEPT INC (VERO) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


What is the market capitalization of VERO stock?

VENUS CONCEPT INC (VERO) has a market capitalization of 4.13M USD. This makes VERO a Nano Cap stock.


VERO Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

VERO Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to VERO. VERO may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

VERO Financial Highlights

Over the last trailing twelve months VERO reported a non-GAAP Earnings per Share(EPS) of -50.78. The EPS increased by 44.91% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -65.52%
ROE -1776.32%
Debt/Equity 6.82
Chartmill High Growth Momentum
EPS Q2Q%76.07%
Sales Q2Q%-5.37%
EPS 1Y (TTM)44.91%
Revenue 1Y (TTM)-13.9%

VERO Forecast & Estimates

For the next year, analysts expect an EPS growth of 76.72% and a revenue growth -9.41% for VERO


Analysts
Analysts45.71
Price TargetN/A
EPS Next Y76.72%
Revenue Next Year-9.41%

VERO Ownership

Ownership
Inst Owners13.23%
Ins Owners0.78%
Short Float %5.59%
Short Ratio0.99